Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast

NCT03304080 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms
Breast Diseases

Interventions

DRUG: Anastrozole
DRUG: Palbociclib
DRUG: Trastuzumab
DRUG: Pertuzumab

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]
[object Object]
[object Object]